All In Biotech

Drug Trial Radar · NCT01573923

Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis

Clinical Trial of Umbilical Mesenchymal Stem Cells Transplantation for Liver Cirrhosis-Phase I/II

Last checked: Nov 19, 2026Latest source record: Apr 14, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

320

Planned (sponsor's estimate)

Start

Jul 2014

Primary completion

Jul 2015

Study completion Oct 2015

Sponsor

Sponsor type
Industry
First posted
Apr 10, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 30 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Liver cirrhosis and subsequent liver failure are leading causes of morbidity and mortality worldwide. Alcohol abuse and viral hepatitis are the most common causes of cirrhosis. Novel therapies are necessary to prevent or block the process of the disease. In this current prospective cohort, the investigators plan to organize four hospitals to determine the safety and efficacy of intravenous administration of umbilical mesenchymal stem cells in the treatment of patients with liver cirrhosis in next three years.

Conditions

  • Liver Cirrhosis

Interventions

  • mesenchymal stem cellsBiological

    Conventional therapy plus UC-MSC intravenous administration (4x107/40ml, once per three months, four times in one year)

  • Conventional therapyBiological

    Conventional therapy without cell therapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. survival timeTime frame: 3-year follow up

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • The 302 Hospital of Chinese People's Liberation Army

    Beijing, Beijing Municipality, China · Recruiting

  • the First Affiliated Hospital of Lanzhou University

    Lanzhou, Gansu, China · Recruiting

  • Hainan BOAO Life infinity international anti-aging medical center

    Qionghai, Hainan, China · Recruiting

  • The first people's hospital of Lianyungang

    Lianyungang, Jiangsu, China · Recruiting

  • Tongji Hospital of Tongji University

    Shanghai, Shanghai Municipality, China · Recruiting

  • The 323 Hospital of Chinese People's Liberation Army

    Xi’an, Shanxi, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.